Craig Collard Biography and Net Worth

Director of Opiant Pharmaceuticals

Mr. Craig Collard is currently the CEO of Veloxis Pharmaceutics, Inc., a transplant focused pharmaceutical company, now a subsidiary of Asahi Kasei after its acquisition of Veloxis for $1.3 billion in 2020. Prior to this, he served as the CEO and Chairman of Cornerstone Therapeutics, Inc., a pharmaceutical company he founded in 2004, until February 2014 when the company was purchased by Chiesi Pharmaceuticals, Inc. Before founding Cornerstone, Mr. Collard served as President and CEO of Carolina Pharmaceuticals, Inc., a pharmaceutical company he founded in May 2003. From 1998 to 2003, Mr. Collard served in various commercial roles at Verum Pharmaceuticals, Inc., and DJ Pharma, Inc. Mr. Collard is a member of the Board of Directors of Veloxis, Sierra Oncology and TerrAscend Corporation. Mr. Collard holds a B.S. in Engineering from the Southern College of Technology (now Southern Polytechnic State University) in Marietta, Georgia.

What is Craig A. Collard's net worth?: The estimated net worth of Craig A. Collard is at least $0.00 as of November 16th, 2023. Mr. Collard owns 186,496 shares of Opiant Pharmaceuticals stock worth more than $0 as of December 22nd. This net worth evaluation does not reflect any other investments that Mr. Collard may own. Learn More about Craig A. Collard's net worth.
How do I contact Craig A. Collard?: The corporate mailing address for Mr. Collard and other Opiant Pharmaceuticals executives is 233 WILSHIRE BLVD. SUITE 280, SANTA MONICA CA, 90401. Opiant Pharmaceuticals can also be reached via phone at (310) 598-5410 and via email at [email protected]. Learn More on Craig A. Collard's contact information.
Has Craig A. Collard been buying or selling shares of Opiant Pharmaceuticals?: Craig A. Collard has not been actively trading shares of Opiant Pharmaceuticals within the last three months. Learn More on Craig A. Collard's trading history.
Who are Opiant Pharmaceuticals' active insiders?: Opiant Pharmaceuticals' insider roster includes Craig Collard (Director), Roger Crystal (CEO), David O'Toole (CFO), Matthew Ruth (Insider), Michael Sinclair (Director), Phil Skolnick (Insider), and Thomas Thomas (Director). Learn More on Opiant Pharmaceuticals' active insiders.

Craig A. Collard Insider Trading History at Opiant Pharmaceuticals

Craig A. Collard Buying and Selling Activity at Opiant Pharmaceuticals

Opiant Pharmaceuticals Company Overview

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.

Today's Range

Now: N/A

50 Day Range

MA: $20.58

$20.03

$21.10

2 Week Range

Now: N/A

Volume

562,700 shs

Average Volume

77,920 shs

Market Capitalization

$108.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now